Css LLC Il bought a new position in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 45,612 shares of the business services provider's stock, valued at approximately $828,000. Css LLC Il owned approximately 0.14% of Cross Country Healthcare at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of CCRN. Quadrant Capital Group LLC purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at approximately $25,000. Plato Investment Management Ltd bought a new stake in Cross Country Healthcare during the 4th quarter valued at $46,000. Mint Tower Capital Management B.V. bought a new stake in Cross Country Healthcare during the 4th quarter valued at $182,000. Guggenheim Capital LLC purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth $201,000. Finally, Envestnet Asset Management Inc. bought a new position in shares of Cross Country Healthcare during the 4th quarter worth $217,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Cross Country Healthcare Price Performance
Shares of CCRN stock opened at $13.77 on Thursday. The stock's 50-day moving average is $14.28 and its 200 day moving average is $15.52. Cross Country Healthcare, Inc. has a 1-year low of $9.58 and a 1-year high of $18.50. The company has a market cap of $451.42 million, a P/E ratio of -275.34, a PEG ratio of 3.32 and a beta of 0.38.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. The firm's revenue for the quarter was down 22.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.19 EPS. On average, analysts anticipate that Cross Country Healthcare, Inc. will post 0.53 EPS for the current year.
Analysts Set New Price Targets
CCRN has been the subject of several recent research reports. JMP Securities restated a "market perform" rating on shares of Cross Country Healthcare in a report on Thursday, February 6th. StockNews.com initiated coverage on shares of Cross Country Healthcare in a research report on Thursday, May 15th. They set a "hold" rating on the stock. UBS Group reduced their price target on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating for the company in a report on Tuesday, May 13th. Finally, Barrington Research reiterated a "market perform" rating and set a $18.61 price objective on shares of Cross Country Healthcare in a research note on Friday, March 14th. Seven equities research analysts have rated the stock with a hold rating, According to MarketBeat, Cross Country Healthcare presently has a consensus rating of "Hold" and an average target price of $17.93.
View Our Latest Stock Report on Cross Country Healthcare
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also
Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.